contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


partner-to-izafe-group-wins-procurement-of-medication-robots-worth-approximately-37-43-msek

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions for home medication management. The company offers, among other things, a medication robot, SaaS solutions and a connected dosing bag. The products aim to reduce the risk of medication errors. Customers include individuals, pharmaceutical companies and public and private healthcare providers globally. iZafe Group is headquartered in Stockholm.

Izafe Group

iZafe Group AB ("iZafe Group") announces that their partner Zafe Care Systems AB ("Zafe") has been awarded a contract in a procurement process with Kristianstad Municipality for the provision...

<div class="mfn-preamble"><p><strong>iZafe Group AB ("iZafe Group") announces that their partner Zafe Care Systems AB ("Zafe") has been awarded a contract in a procurement process with Kristianstad Municipality for the provision of iZafe's medication dispensers Dosell. The procurement includes 150-190 units, with an estimated value of 3.7-4.3 MSEK. The contract is between Zafe and iZafe Group's wholly owned subsidiary Dosell AB.</strong></p></div><div class="mfn-body"><p>The contract period extends over four years, from 2024 to 2028. The order value of 3.7-4.3 MSEK reflects the total value for Dosell and iZafe Group.</p><p>"It is an honor to collaborate with a leading player in automated medication dispensing. With Dosell, we can ensure that patients receive the right medication at the right time, reducing the risk of medication errors and increasing security for both patients and their relatives. Together with Sensorem, we can further enhance patient independence by reminding them to take their medication on time. Our technology creates independence and security, and we are proud to contribute to safer healthcare.</p><p>Zafe stands for down-to-earth and caring service, always with flexible solutions tailored to individual needs." says Per La Fleur, CEO of Zafe Care Systems.</p></div><div class="mfn-footer mfn-contacts mfn-56636653838f"><p><strong class="mfn-heading-1">Contacts</strong></p><hr><p>Anders&nbsp;Segerström, Chief Executive Officer&nbsp;<br>E-mail: <a rel="noopener" href="mailto:anders.segerstrom@izafegroup.com">anders.segerstrom@izafegroup.com</a><br>Phone&nbsp;number: <a rel="noopener">+46 70-875 14 12</a><br><br>iZafe Group AB (publ.) <br>David Bagares gata 3<br>111 38 Stockholm</p><p>E-mail:&nbsp;<a rel="noopener" href="mailto:ir@izafegroup.com">ir@izafegroup.com</a><br><a rel="noopener" href="https://izafe.se/en/">www.izafegroup.com</a><br><a rel="noopener" href="https://eucaps.com/izafe-group">eucaps.com/izafe-group</a></p></div><div class="mfn-footer mfn-about mfn-2ae9e9120422"><p><strong class="mfn-heading-1">About iZafe Group AB (publ.)</strong></p><hr><p>iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.</p><p>The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution Pilloxa with the smart pillbox. The company's solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.</p><p>The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.</p><p>iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. Mangold Fondkommission AB is the company's Certified Adviser. Further information is available at <a rel="noopener" href="http://www.izafegroup.com">www.izafegroup.com</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-image"><p><strong class="mfn-heading-1">Image Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/64db19e4-e5a1-44b5-81b5-45b1ef9930db/sjalvstandig-medicinering-hemtjanst.png">Självständig Medicinering Hemtjänst</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/83feb6f8-28f4-4a5d-93d5-b2bbbb7cea71/partner-to-izafe-group-wins-procurement-of-medication-robots-worth-approximately-3-7-4-3-msek.pdf" class="mfn-generated mfn-primary">Partner to iZafe Group wins procurement of medication robots worth approximately 3.7-4.3 MSEK</a></p></div>

Partner to iZafe Group wins procurement of medication robots worth approximately 3.7-4.3 MSEK